T099: High efficacy and durability of second-line therapy with pembrolizumab, gemcitabine, vinorelbine, and liposomal doxorubicin in the phase II study for relapsed and refractory Hodgkin lymphoma - Moskowitz, AJ; Shah, G; Schöder, H (HemaSphere, 2022)
et al.